SO
DICE

STRS Ohio’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

STRS Ohio’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,200
Closed -$61K – 2365
2022
Q1 		$61K Hold
3,200
– – ﹤0.01% 1921
2021
Q4 		$80K Buy
+3,200
New +$93.8K ﹤0.01% 1936

Other funds holding DICE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

STRS Ohio's DICE Position: Q2 2022 in Review

STRS Ohio sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q2 2022, closing a stake of 3,200 shares — an estimated $61K sold.

STRS Ohio first reported a position in DICE in Q4 2021 and held it in 2 quarters. The position peaked at $80K in Q4 2021. 80 funds tracked by Wall St. Rank hold DICE as of Q2 2022.

  • STRS Ohio reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • STRS Ohio sold 3,200 DICE Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $61K.
  • STRS Ohio first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • STRS Ohio's DICE Therapeutics, Inc. Common Stock position peaked at $80K in Q4 2021.
  • 80 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.